CMC Regulatory Workshop @ filings and how they relate to IP (WS10)
- Date:
- 30 April 2019
- Time:
- -
- Available Seats:
- 22
The CMC section of the IND contains information that has a direct influence on clinical trial supplies and failure to prepare IP that follows the requirements listed in that section can cause significant impact to a clinical trial. This session will discuss the CMC information contained in a clinical trial regulatory filing and how it should be monitored to avoid issues wth clinical supplies.
